To recover your password please fill in your email address
Please fill in below form to create an account with us
The NHMRC Clinical Trials Centre (CTC) continued to grow and celebrate multiple milestones in 2022. By December, we had over 100 active trials including 11 that began recruiting this year and 15 in start up.
There have been many research achievements during the last year of which we are particularly proud. Highlights include several studies that have the potential to change policy and practice around the world.
We continued to call on our leading status as a clinical trials research centre to help address the COVID-19 pandemic and currently have six trials in this area.
INNOVATION IN TRIALS
A key focus for CTC in 2022 and beyond is to look at ways to improve the science and delivery of trials, generating evidence in efficient ways to maximise learnings.
2022 saw the success of two new initiatives to support the development of new or early-stage collaborative research across the CTC and The University of Sydney.
Finally, we were delighted to welcome four new senior appointments to the CTC in 2022. Rebecca Osborne joined in June as Chief Operating Officer bringing invaluable experience from commercial and academic scientific research organisations in Australia, Canada, and the USA. Professor Rob Sanders also joined in June as Critical Care Lead. Rob's research focusses on optimizing outcomes from perioperative and critical care, especially centred on delirium and cognition. Dr Katharina Bell has accepted a position as Ophthalmology Lead and will be joining us in January 2023. Katharina is an ophthalmologist and Clinician-Scientist interested in translational research approaches in ophthalmology. Professor David Beard has also accepted a position as Surgical and Complex Interventions Lead. David is currently based at Oxford University and will begin transitioning his major focus of activities over the next year.
THANK YOU TO OUR COLLABORATORS AND TEAM
The trials and achievements outlined above demonstrate our effort to advance the boundaries of care and treatment, with the wellbeing of trial participants front of mind. These and other successes would not be possible without our collaborators, and most of all, without the efforts of our outstanding team of dedicated, committed, enthusiastic trial staff with their shared vision of making a difference.
We have every confidence that the CTC, with such an outstanding team of researchers working in partnership with key collaborators, will continue to make a profound impact on future practice and health.